日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

KRAS Withdrawal in Cholangiocarcinoma Leads to Immune Infiltration and Tumor Regression

胆管癌中KRAS基因撤除可导致免疫浸润和肿瘤消退

Qiao, Youwei; Yee, Matthew F; Parikh, Chaitanya N; Ma, Boyang; Cao, Yueying; Shih, Yu-Huan; Wu, Joae Qiong; Ruscetti, Marcus; Liang, Shun-Qing; Xue, Wen

Tumor Homing Nanoparticle Immunotherapy for Acute Clearance and Mitigation of T-cell Exhaustion in Humanized High-Risk Neuroblastoma

肿瘤靶向纳米颗粒免疫疗法用于人源化高危神经母细胞瘤的急性清除和T细胞耗竭缓解

Kane, Griffin I; Diaz-Infante, Miranda B; Wigglesworth, Kim; Lusi, Ellis; Brassil, Meghan; Rozen, Esteban J; Kady, Jamie; Mori, Haruka; Lukas, John; Naylor, Tiana; Dinnell, Ronnie W; Murphy, Katherine C; Alarcon, Christian Bernard B; Ruscetti, Marcus; Brehm, Michael; Shohet, Jason M; Atukorale, Prabhani U

P21-positive senescent stromal cells promote prostate cancer immune suppression and progression that can be reversed by senolytic therapy

P21阳性衰老基质细胞促进前列腺癌免疫抑制和进展,而衰老细胞清除疗法可以逆转这一过程。

Lin Zhou ,Kelly D DeMarco ,Katherine C Murphy ,Zhenpeng Wu ,Jinping Li ,Calvin Johnson ,Bin Liu ,Hadiya K Giwa ,Boyang Ma ,Nikita Bhalerao ,Junhui Li ,Zhong Jiang ,Shi Bai ,Chaitanya N Parikh ,Tianyi Ye ,Karl Simin ,Lihua J Zhu ,Jason R Pitarresi ,Hong Wu ,Marcus Ruscetti

Cellular senescence offers distinct immunological vulnerabilities in cancer

细胞衰老为癌症提供了独特的免疫学脆弱性。

Zhou, Lin; Ma, Boyang; Ruscetti, Marcus

MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T Cell and Immunotherapy Responses in Prostate Cancer.

MYC 和 p53 的改变通过 VEGF 信号传导协同作用,抑制前列腺癌中的细胞毒性 T 细胞和免疫疗法反应

Murphy Katherine C, DeMarco Kelly D, Zhou Lin, Peura Jessica, Giwa Hadiya K, Lopez-Diaz Yvette, Ho Yu-Jui, Li Junhui, Bai Shi, Simin Karl, Zhu Lihua J, Pitarresi Jason R, Mercurio Arthur M, Ruscetti Marcus

Parkin activates innate immunity and promotes antitumor immune responses

帕金蛋白激活先天免疫并促进抗肿瘤免疫反应

Perego, Michela; Yeon, Minjeong; Agarwal, Ekta; Milcarek, Andrew T; Bertolini, Irene; Camisaschi, Chiara; Ghosh, Jagadish C; Tang, Hsin-Yao; Grandvaux, Nathalie; Ruscetti, Marcus; Kossenkov, Andrew V; Preston-Alp, Sarah; Tempera, Italo; Auslander, Noam; Altieri, Dario C

Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity

线粒体Ca2+通过调节上皮细胞可塑性来控制胰腺癌的生长和转移

Jillian S Weissenrieder,Jessica Peura,Usha Paudel,Nikita Bhalerao,Natalie Weinmann,Calvin Johnson,Maximilian Wengyn,Rebecca Drager,Emma Elizabeth Furth,Karl Simin,Marcus Ruscetti,Ben Z Stanger,Anil K Rustgi,Jason R Pitarresi,J Kevin Foskett

SPARC: A Multipayload ADC Architecture for Programmable Drug Combinations

SPARC:一种用于可编程药物组合的多有效载荷ADC架构

Sun, Wenlong; Weng, Weining; Shi, Jing; Ma, Boyang; D DeMarco, Kelly; Gui, Fu; Jin, Rui; Ruscetti, Marcus; Jia, Li; Hu, Wenhao; Shi, Yu; Meng, Xun

Pancreatic cancer cachexia is mediated by PTHrP-driven disruption of adipose de novo lipogenesis.

胰腺癌恶病质是由 PTHrP 驱动的脂肪组织从头脂肪生成紊乱介导的

Bhalerao Nikita, Ogoti Yamini, Peura Jessica, Johnson Calvin, Chen Qingbo, Korobkina Ekaterina D, Keller Faith N, Wengyn Maximilian, Norgard Robert J, Shamber Claire, Klute Kelsey, DiMaio Dominick, Sellin Karine, Grandgenett Paul M, Li Rui, Hollingsworth Michael A, Guilherme Adilson, Czech Michael P, Kremer Richard, Zhu Lihua Julie, Spinelli Jessica B, Watson Emma V, Ruscetti Marcus, Guertin David A, Pitarresi Jason R

Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer

纳米颗粒递送先天免疫激动剂联合衰老诱导剂可促进T细胞对胰腺癌的控制

Loretah Chibaya ,Kelly D DeMarco ,Christina F Lusi ,Griffin I Kane ,Meghan L Brassil ,Chaitanya N Parikh ,Katherine C Murphy ,Shreya R Chowdhury ,Junhui Li ,Boyang Ma ,Tiana E Naylor ,Julia Cerrutti ,Haruka Mori ,Miranda Diaz-Infante ,Jessica Peura ,Jason R Pitarresi ,Lihua Julie Zhu ,Katherine A Fitzgerald ,Prabhani U Atukorale ,Marcus Ruscetti